Yuncui Yu
No.56 Nanlishi Road
Beijing, 100045, China
Beijing, 100045, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia.
Journal: British journal of haematology
Published: March 15, 2026
Baloxavir Marboxil in Chinese Pediatric Patients Aged 1 to < 5 Years with Influenza: Safety and Clinical and Virologic Outcomes.
Journal: Infectious diseases and therapy
Published: August 27, 2025
Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis.
Journal: Healthcare (Basel, Switzerland)
Published: July 25, 2025
Proteomic profiling of cerebrospinal fluid reveals pathophysiology changes and diversity of treatment response in pediatric Streptococcus pneumoniae meningitis.
Journal: Expert review of proteomics
Published: July 24, 2025
Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.
Journal: Frontiers in cellular and infection microbiology
Published: July 09, 2025
Urinary metabolomics predicts early rituximab response in steroid-nonresponsive pediatric patients with primary immune thrombocytopenia.
Journal: Annals of hematology
Published: May 07, 2025
Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid-resistant immune thrombocytopenia.
Journal: British journal of haematology
Published: February 13, 2025
Cost-Effectiveness Analysis of Omalizumab Combined With Standard of Care in Treating Moderate to Severe Asthma Children in China.
Journal: Pediatric pulmonology
Published: August 25, 2024
Budesonide/formoterol maintenance and reliever therapy in childhood asthma: Real-world effectiveness and economic assessment.
Journal: Pediatric pulmonology
Published: March 20, 2023
Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.
Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.
Journal: Clinical proteomics
Published: December 01, 2022
UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment.
Journal: Frontiers in molecular biosciences
Published: July 21, 2022
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma.
Journal: International journal of oncology
Published: July 08, 2022
Last Updated: 09/26/2026